Title:
CURABLE COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2006/051798
Kind Code:
A1
Abstract:
Disclosed is a curable composition having good curability, adhesiveness and storage stability which uses a catalyst other than organic tin catalysts. Specifically disclosed is a curable composition composed of an organic polymer (A) having a reactive silicon-containing group and a silanol condensation catalyst (B) composed of at least one substance selected from organic tin compounds, carboxylic acids and amine compounds. This curable composition is characterized in that at least a part of the reactive silicon-containing group of the organic polymer (A) is a group represented by the following formula (1): -(CR22)2-(SiR12-aXaO)m-SiX3 (1) , and in that the silanol condensation catalyst (B) is composed of an amine compound (B1), or an amine compound (B1) and a carboxylic acid (B2) wherein the total amount of the carboxylic acid is not more than 0.1 in molar ratio assuming the amount of amine compound is 1.
Inventors:
WAKABAYASHI KATSUYU (JP)
MATSUSHITA NORIKO (JP)
OKAMOTO TOSHIHIKO (JP)
MATSUSHITA NORIKO (JP)
OKAMOTO TOSHIHIKO (JP)
Application Number:
PCT/JP2005/020500
Publication Date:
May 18, 2006
Filing Date:
November 09, 2005
Export Citation:
Assignee:
KANEKA CORP (JP)
WAKABAYASHI KATSUYU (JP)
MATSUSHITA NORIKO (JP)
OKAMOTO TOSHIHIKO (JP)
WAKABAYASHI KATSUYU (JP)
MATSUSHITA NORIKO (JP)
OKAMOTO TOSHIHIKO (JP)
International Classes:
C08L101/10; C08K5/09; C08K5/17; C08K5/57; C09J201/10; C09K3/10
Foreign References:
JP2003206410A | 2003-07-22 | |||
JP2003055511A | 2003-02-26 | |||
JPH0841358A | 1996-02-13 | |||
JPH11124509A | 1999-05-11 |
Other References:
See also references of EP 1816168A4
Attorney, Agent or Firm:
KANEKA CORPORATION (Osaka-shi Osaka, 88, JP)
Download PDF:
Previous Patent: THERAPEUTIC AGENT FOR INTERSTITIAL CYSTITIS
Next Patent: MUTANT INTERFERON &agr PROTEINS AND USE THEREOF
Next Patent: MUTANT INTERFERON &agr PROTEINS AND USE THEREOF